Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373
Medical Marijuana Program Connection
MARCH 23, 2023
–(BUSINESS WIRE)–Enveric Biosciences, Inc. NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel. CAMBRIDGE, Mass.–(BUSINESS Read More
52 
Let's personalize your content